Tag: bioequivalence studies

Bioequivalence Studies: What the FDA Requires Manufacturers to Prove

• 14 Comments
• Feb, 7 2026

The FDA requires generic drug manufacturers to prove bioequivalence through rigorous pharmacokinetic studies, ensuring their products match the brand-name drug in absorption and effectiveness. This process is critical for patient safety and drug affordability.